vimarsana.com

HC Wainwright reaffirmed their buy rating on shares of Clene (NASDAQ:CLNN – Free Report) in a report issued on Tuesday, Benzinga reports. The brokerage currently has a $7.00 price target on the stock. Separately, Benchmark reissued a buy rating and set a $5.00 target price on shares of Clene in a research note on Thursday, […]

Related Keywords

,Nasdaq ,Exchange Commission ,Silverarc Capital Management ,Clene Inc ,Clene Company Profile ,Free Report ,Get Free Report ,Capital Management ,Multiple Sclerosis ,Clene Daily ,

© 2024 Vimarsana

vimarsana.com © 2020. All Rights Reserved.